19/5/2021
We are delighted that the Medicines and Healthcare Regulation Authority have issued new prescribing advice for patients who experience symptoms on switching between different levothyroxine products.
If a patient reports persistent symptoms when switching between different levothyroxine tablet formulations, prescribers are now advised to consider consistently prescribing a specific product known to be well tolerated by the patient. If symptoms or poor control of thyroid function persist (despite adhering to a specific product), they should consider prescribing levothyroxine in an oral solution formulation.
Read the full advice on the UK government website.
If a patient reports persistent symptoms when switching between different levothyroxine tablet formulations, prescribers are now advised to consider consistently prescribing a specific product known to be well tolerated by the patient. If symptoms or poor control of thyroid function persist (despite adhering to a specific product), they should consider prescribing levothyroxine in an oral solution formulation.
Read the full advice on the UK government website.
Well done to everyone who has experienced difficulties with different formulations of levothyroxine from different manufacturers and has taken the time and trouble to report to MHRA using the Yellow Card Scheme!
If you experience issues with any medication it is really important to report them. This announcement is evidence that the authorities do listen and things can change.
Some people find that the different fillers in different formulations of levothyroxine do not agree with them. When that happens the best solution is to stick with the formulation that works well for the patient, or to prescribe liquid levothyroxine which doesn't contain any fillers. Many patients and doctors have known this for some time but to have it stated unequivocally in official advice is extremely helpful for those patients who have struggled to be taken seriously by their doctors, since not all GPs are always up to date with every aspect of every condition they treat.
Thank you to MHRA!
If you experience issues with any medication it is really important to report them. This announcement is evidence that the authorities do listen and things can change.
Some people find that the different fillers in different formulations of levothyroxine do not agree with them. When that happens the best solution is to stick with the formulation that works well for the patient, or to prescribe liquid levothyroxine which doesn't contain any fillers. Many patients and doctors have known this for some time but to have it stated unequivocally in official advice is extremely helpful for those patients who have struggled to be taken seriously by their doctors, since not all GPs are always up to date with every aspect of every condition they treat.
Thank you to MHRA!
for everyone affected by thyroid disease
We are a small independent charity. We receive no government funding and are reliant on donations for our income. Please support us.
PlEASE CONSIDER SUPPORTING OUR VITAL WORKThe donate button above takes you to a secure donation processing platform, JustGiving
Please contact us if you would prefer to make a direct bank transfer to donate via any other means, or if you are interested in volunteering. Proud members of the following organisations
|
|
|
|
|
|
|
|
Supported by National Lottery Community Fund. Thank you to all National Lottery players.
Supported by Garfield Weston Foundation.
Correspondence ADDRESS71-75 Shelton Street, London, WC2H 9JQ
The Thyroid Trust is also known as TTT and Thyroid Friends Network,
Registered Charity Number 1183292 Registered Address: 15 GREAT COLLEGE STREET, LONDON, SW1P 3RX Copyright asserted 2019 - Our consititution and all policy documents can be viewed on request. Read our Privacy Policy updated 23/5/18, . |
|